FWL Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.19M Buy
1,289
+1,084
+529% +$1.1M 0.26% 52
2025
Q4
$220K Buy
205
+42
+26% +$40.2K 0.05% 83
2025
Q3
$124K Sell
163
-25
-13% -$18.6K 0.03% 103
2025
Q2
$147K Buy
188
+42
+29% +$32.6K 0.04% 100
2025
Q1
$121K Buy
146
+22
+18% +$18.3K 0.04% 100
2024
Q4
$95.7K Hold
124
0.03% 115
2024
Q3
$110K Hold
124
0.04% 92
2024
Q2
$112K Sell
124
-30
-19% -$24K 0.06% 68
2024
Q1
$120K Buy
154
+42
+38% +$29.9K 0.07% 66
2023
Q4
$65.3K Buy
112
+25
+29% +$14.6K 0.04% 84
2023
Q3
$46.7K Buy
+87
New +$44.8K 0.03% 93
2023
Q1
Sell
-9
Closed -$3.29K 140
2022
Q4
$3.29K Buy
+9
New +$3.19K ﹤0.01% 163

Other funds holding LLY

FWL Investment Management's LLY Position: Q1 2026 in Review

FWL Investment Management increased its Eli Lilly (LLY) stake by 529% in Q1 2026, buying an estimated $1.1M and bringing the position to 1,289 shares worth $1.19M. The position accounts for 0.26% of the portfolio, ranked #52.

FWL Investment Management first reported a position in LLY in Q4 2022 and has held it in 12 quarters since. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • FWL Investment Management held 1,289 shares of Eli Lilly worth $1.19M as of Q1 2026.
  • FWL Investment Management bought 1,084 Eli Lilly shares in Q1 2026, an estimated $1.1M.
  • Eli Lilly made up 0.26% of FWL Investment Management's portfolio in Q1 2026, its #52 holding.
  • FWL Investment Management first reported a position in Eli Lilly in Q4 2022 and has held it in 12 quarters since.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on FWL Investment Management's 13F filing for Q1 2026, filed 15 May 2026.